These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7688897)

  • 1. CDw75 antigen expression in breast lesions.
    Reed W; Erikstein BK; Funderud S; Lilleng R; Tvedt K; Nesland JM
    Pathol Res Pract; 1993 May; 189(4):394-8. PubMed ID: 7688897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDw75 antigen expression in human gastric carcinoma and adjacent mucosa.
    David L; Nesland JM; Funderud S; Sobrinho-Simões M
    Cancer; 1993 Sep; 72(5):1522-7. PubMed ID: 8348485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle-dependent regulation of CDw75 (beta-galactoside alpha-2,6-sialyltransferase) on human B lymphocytes.
    Erikstein BK; Funderud S; Beiske K; Aas-Eng A; De Lange Davies C; Blomhoff HK; Smeland EB
    Eur J Immunol; 1992 May; 22(5):1149-55. PubMed ID: 1577059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the CDw75 (beta-galactoside alpha 2,6-sialyltransferase) antigen on normal blood cells and in B-cell chronic lymphocytic leukaemia.
    Guy K; Andrew JM
    Immunology; 1991 Oct; 74(2):206-14. PubMed ID: 1721040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic evaluation of CDw75 antigen expression in colorectal adenocarcinomas.
    Elpek GO; Gelen T; Karpuzoglu G; Karpuzoglu T; Aksoy NH; Keles N
    Pathol Oncol Res; 2002; 8(3):175-82. PubMed ID: 12515997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic evaluation of CDw75 antigen expression in patients with gastric carcinoma.
    Elpek GO; Gelen T; Karpuzoğlu G; Karpuzoğlu T; Keles N
    J Pathol; 2001 Feb; 193(2):169-74. PubMed ID: 11180162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of tumor marker CDw75 and its clinical impact in gastric carcinoma].
    Li HX; Shen ZX; Tan SY
    Ai Zheng; 2003 Jan; 22(1):83-5. PubMed ID: 12561443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changed expression of 9-O-acetyl GD3 (CDw60) in benign and atypical proliferative lesions and carcinomas of the human breast.
    Gocht A; Rutter G; Kniep B
    Histochem Cell Biol; 1998 Sep; 110(3):217-29. PubMed ID: 9749956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and expression of CDw75 antigen in human colorectal cancer.
    Costa-Nogueira C; Villar-Portela S; Cuevas E; Gil-Martín E; Fernández-Briera A
    BMC Cancer; 2009 Dec; 9():431. PubMed ID: 20003255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase.
    Bast BJ; Zhou LJ; Freeman GJ; Colley KJ; Ernst TJ; Munro JM; Tedder TF
    J Cell Biol; 1992 Jan; 116(2):423-35. PubMed ID: 1730763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast.
    Concha A; Ruiz-Cabello F; Cabrera T; Nogales F; Collado A; Garrido F
    Eur J Immunogenet; 1995 Aug; 22(4):299-310. PubMed ID: 7495782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Golgi beta-galactoside alpha-2,6-sialyltransferase generates a group of sialylated B lymphocyte differentiation antigens.
    Keppler OT; Moldenhauer G; Oppenländer M; Schwartz-Albiez R; Berger EG; Funderud S; Pawlita M
    Eur J Immunol; 1992 Nov; 22(11):2777-81. PubMed ID: 1425905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of immunoperoxidase staining of 3 different types of CD5 antibodies in a spectrum of breast lesions.
    Walsh R; Peston D; Shousha S
    Arch Pathol Lab Med; 2001 Jun; 125(6):781-4. PubMed ID: 11371230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinases and sialyltransferase in human breast tumors.
    Abecassis J; Collard R; Eber M; Pusel J; Fricker JP; Methlin G
    Int J Cancer; 1984 Jun; 33(6):821-4. PubMed ID: 6329971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody B72.3 in benign breast lesions.
    Soomro S; Shousha S
    J Clin Pathol; 1990 Dec; 43(12):1026-8. PubMed ID: 2266175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HB4 antibody recognizes a carbohydrate structure on lymphocyte surface proteins related to HB6, CDw75, and CD76 antigens.
    De Lau WB; Kuipers J; Voshol H; Clevers H; Bast BJ
    J Immunol; 1993 Jun; 150(11):4911-9. PubMed ID: 8496593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of UN1, early thymocyte-associated sialoglycoprotein, in breast normal tissue, benign disease and carcinomas.
    Tassone P; Bonelli P; Tuccillo F; Bond HM; D'Armiento FP; Galea E; Palmieri C; Tagliaferri P; Natali PG; Venuta S
    Anticancer Res; 2002; 22(4):2333-40. PubMed ID: 12174923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of a monoclonal antibody with tissues and tumors from the human breast. Immunohistochemical localization of a new antigen and clinicopathologic correlations.
    Mariani-Costantini R; Barbanti P; Colnaghi MI; Ménard S; Clemente C; Rilke F
    Am J Pathol; 1984 Apr; 115(1):47-56. PubMed ID: 6711680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack?
    Hofman P; Hsi BL; Manie S; Fenichel P; Thyss A; Rossi B
    Breast Cancer Res Treat; 1994; 32(2):213-9. PubMed ID: 7532466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast carcinoma-associated antigen. An immunocytochemical study.
    Yu GS; Kadish AS; Johnson AB; Marcus DM
    Am J Clin Pathol; 1980 Oct; 74(4):453-7. PubMed ID: 6999888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.